Mode
Text Size
Log in / Sign up

Doxycycline is the best supported alternative to benzathine penicillin for treating infectious syphilisDoxycycline shows promise as syphilis treatment alternative

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that doxycycline is the best supported alternative to benzathine penicillin for infectious syphilis.

This systematic review and network meta-analysis evaluates treatment regimens for infectious syphilis in adult and adolescent participants. The analysis compared benzathine penicillin, ceftriaxone, and doxycycline to determine the most effective options for achieving a clinical and serologic cure.

The authors report that a regimen of benzathine penicillin followed by ceftriaxone and then doxycycline was superior to benzathine penicillin alone. Additionally, doxycycline compared with the standard of care showed an OR of 6.88 (lower CrI 0.14) in favor of doxycycline.

However, the authors note that the evidence quality is low for randomized controlled trials and very low for observational studies. Practical limitations regarding the multi-drug regimen of benzathine penicillin, ceftriaxone, and doxycycline were also noted.

Clinically, doxycycline is identified as the best supported alternative to benzathine penicillin. However, the superiority of the multi-drug regimen should be interpreted with caution due to the low quality of the evidence.

How this fits prior evidence

This systematic review addresses the selection of alternative treatments for infectious syphilis. While it does not directly relate to the previously reported 84% reduction in stillbirth odds for treated maternal syphilis, it provides a comparative analysis of antibiotic options including doxycycline and ceftriaxone. It also provides a different context for ceftriaxone use than the report on topoisomerase II inhibitors for gonorrhoea.

Syphilis is a sexually transmitted infection that can cause serious health problems if left untreated. For decades, the standard treatment has been a shot of benzathine penicillin. But what if you're allergic to penicillin, or it's not available? A new review of the evidence suggests there may be another option: doxycycline, an antibiotic pill.

Researchers looked at data from 1,623 adults and adolescents with infectious syphilis. They compared different treatment regimens to the usual penicillin shot. The results, published as a systematic review and network meta-analysis, suggest that doxycycline might be more effective than penicillin at curing syphilis. In fact, the odds of cure were nearly seven times higher with doxycycline compared to standard care, though the range of uncertainty was wide.

The review also found that a regimen of penicillin followed by ceftriaxone and then doxycycline appeared to work better than penicillin alone. However, the researchers caution that this finding is based on low-quality evidence, so it should be interpreted with care.

It's important to note that the overall level of evidence was low for clinical trials and very low for observational studies. This means we can't be completely confident in these results. Also, the practicalities of the three-drug regimen might make it hard to use in real life.

If you have syphilis and can't take penicillin, talk to your doctor about whether doxycycline might be a good option for you. This review offers hope, but more research is needed to confirm these findings.

What this means for you:
Doxycycline may be a good alternative for syphilis when penicillin isn't an option, but evidence is weak.

Common questions

What is doxycycline?

Doxycycline is an antibiotic that you take by mouth. It's commonly used to treat various bacterial infections. In this review, it was studied as a possible treatment for syphilis, especially for people who can't take penicillin.

Is doxycycline as good as penicillin for syphilis?

The review found that doxycycline might be more effective than penicillin, with an odds ratio of 6.88. However, the evidence is low quality, so we can't be sure. Penicillin remains the standard treatment, but doxycycline could be an option if penicillin isn't suitable.

Who might benefit from doxycycline for syphilis?

People who are allergic to penicillin or who don't have access to it might benefit from doxycycline. The review included adults and adolescents with infectious syphilis. If you're in this situation, talk to your doctor about your options.

What are the side effects of doxycycline?

The review did not report on side effects. Doxycycline can cause stomach upset, sun sensitivity, and other effects, but this study didn't provide details. Always discuss potential side effects with your healthcare provider.

Study Details

Study typeSystematic review
Sample sizen = 1,623
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
BACKGROUND: Given increasing rates of syphilis and shortages of the first-line agent benzathine penicillin, alternative treatment options are needed. This systematic review examined the existing evidence for alternative treatment regimens for infectious syphilis. METHODS: We searched MEDLINE and EMBASE from January 15, 2021 to January 15, 2025, including eligible studies from two previously published systematic reviews. A systematic review with network meta-analysis (NMA) of randomized controlled trials (RCTs) and a meta-analysis of observational studies was conducted when appropriate. RCTs, cohort studies, case-control studies, and cross-sectional studies published in English that included adult and adolescent participants with infectious syphilis comparing two or more treatment regimens for syphilis were eligible. Risk of bias was assessed using the Cochrane RoB2 tool and Newcastle-Ottawa Scale, and a GRADE assessment was performed. RESULTS: Fourteen RCTs and 20 observational studies were identified. All studies defined cure based on serologic plus/minus clinical response. Thirteen RCTs were eligible for the NMA, representing 1623 participants and 10 treatments. Benzathine penicillin, followed by ceftriaxone, and then doxycycline was reported to be superior to benzathine penicillin alone. However, considering the low quality of the evidence and practicalities of this regimen, this should be interpreted with caution. All other comparisons did not show statistically significant differences in cure rates. However, the pooled point estimates were in favor of doxycycline compared with the standard of care in the NMA (OR of 6.88, lower CrI 0.14). The level of evidence was low for RCTs and very low for observational studies. CONCLUSIONS: Despite low-quality evidence, doxycycline is the best-supported alternative to benzathine penicillin for syphilis treatment.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.